Tag archive for ‘Tysabri’
Nir Eyal On Tuesday, February 28th, 2017

Perrigo shares down 10% after company reports loss, sells Tysabri Drug Royalties

  Perrigo announced on Monday that it had signed a definitive agreement to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri (natalizumab) to RPI Finance More...

Shiri Habib-Valdhorn On Monday, November 11th, 2013

Perrigo Boosted By FDA Warning On Sanofi SA Drug

– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – CEO Joseph C. Papa – A safety warning by the US Food and More...

Yoel Bermant On Monday, July 29th, 2013

Pharmaceutical industry giant Perrigo wins the $8.6 billion battle for Elan of Ireland

– There’s a lot happening in the pharmaceutical industry these days and one of the biggest deals so far this year will see US based Perrigo swallow up the Eire based Elan. Perrigo are the only non-Israeli More...

Wordpress site Developed by Fixing WordPress Problems